These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32419087)
1. Simultaneous electrical detection of IL-6 and PCT using a microfluidic biochip platform. Berger J; Valera E; Jankelow A; Garcia C; Akhand M; Heredia J; Ghonge T; Liu C; Font-Bartumeus V; Oshana G; Tiao J; Bashir R Biomed Microdevices; 2020 May; 22(2):36. PubMed ID: 32419087 [TBL] [Abstract][Full Text] [Related]
2. A microfluidic biochip platform for electrical quantification of proteins. Valera E; Berger J; Hassan U; Ghonge T; Liu J; Rappleye M; Winter J; Abboud D; Haidry Z; Healey R; Hung NT; Leung N; Mansury N; Hasnain A; Lannon C; Price Z; White K; Bashir R Lab Chip; 2018 May; 18(10):1461-1470. PubMed ID: 29664086 [TBL] [Abstract][Full Text] [Related]
3. Wave-shaped microfluidic chip assisted point-of-care testing for accurate and rapid diagnosis of infections. Yin BF; Wan XH; Yang MZ; Qian CC; Sohan ASMMF Mil Med Res; 2022 Feb; 9(1):8. PubMed ID: 35144683 [TBL] [Abstract][Full Text] [Related]
4. Hierarchically structured microchip for point-of-care immunoassays with dynamic detection ranges. Mou L; Dong R; Hu B; Li Z; Zhang J; Jiang X Lab Chip; 2019 Aug; 19(16):2750-2757. PubMed ID: 31338499 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. Song J; Park DW; Moon S; Cho HJ; Park JH; Seok H; Choi WS BMC Infect Dis; 2019 Nov; 19(1):968. PubMed ID: 31718563 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous Quantitative Detection of IL-6 and PCT Using SERS magnetic immunoassay with sandwich structure. Wang X; Ma L; Hu C; Liu T; Sun S; Liu X; Guan M Nanotechnology; 2021 Mar; 32(25):. PubMed ID: 33711835 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis. Cong S; Ma T; Di X; Tian C; Zhao M; Wang K BMC Infect Dis; 2021 Apr; 21(1):384. PubMed ID: 33902476 [TBL] [Abstract][Full Text] [Related]
8. Is Interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults. Weidhase L; Wellhöfer D; Schulze G; Kaiser T; Drogies T; Wurst U; Petros S BMC Infect Dis; 2019 Feb; 19(1):150. PubMed ID: 30760225 [TBL] [Abstract][Full Text] [Related]
9. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252 [TBL] [Abstract][Full Text] [Related]
10. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639 [TBL] [Abstract][Full Text] [Related]
11. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3. Jekarl DW; Lee S; Kim M; Kim Y; Woo SH; Lee WJ J Clin Lab Anal; 2019 Nov; 33(9):e22996. PubMed ID: 31420921 [TBL] [Abstract][Full Text] [Related]
12. Towards improved point-of-care (POC) testing for patients with suspected sepsis: POC tests for host biomarkers and possible microbial pathogens. Adami ME; Giamarellos-Bourboulis EJ; Polyzogopoulou E Expert Rev Mol Diagn; 2024 Sep; 24(9):829-839. PubMed ID: 39135402 [TBL] [Abstract][Full Text] [Related]
13. [Changes in plasma interleukin-33 concentration in sepsis and its correlation with seriousness of sepsis]. Chang D; Jia J; Zang B Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):138-42. PubMed ID: 25665614 [TBL] [Abstract][Full Text] [Related]
14. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. Anand D; Das S; Bhargava S; Srivastava LM; Garg A; Tyagi N; Taneja S; Ray S J Crit Care; 2015 Feb; 30(1):218.e7-12. PubMed ID: 25263339 [TBL] [Abstract][Full Text] [Related]
15. Streptavidin-biotin-peroxidase nanocomplex-amplified microfluidics immunoassays for simultaneous detection of inflammatory biomarkers. Wu J; Chen Y; Yang M; Wang Y; Zhang C; Yang M; Sun J; Xie M; Jiang X Anal Chim Acta; 2017 Aug; 982():138-147. PubMed ID: 28734353 [TBL] [Abstract][Full Text] [Related]
16. Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis. Liu XW; Ma T; Liu W; Cai Q; Wang L; Song HW; Yuan L; Liu Z J Crit Care; 2018 Jun; 45():14-19. PubMed ID: 29413717 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department]. Zhao Y; Li C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Mándi Y; Farkas G; Takács T; Boda K; Lonovics J Int J Pancreatol; 2000 Aug; 28(1):41-9. PubMed ID: 11185709 [TBL] [Abstract][Full Text] [Related]
19. The diagnostic ability of procalcitonin and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality. Mat-Nor MB; Md Ralib A; Abdulah NZ; Pickering JW J Crit Care; 2016 Jun; 33():245-51. PubMed ID: 26851139 [TBL] [Abstract][Full Text] [Related]